{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:10:25Z","timestamp":1784409025803,"version":"3.55.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hungarian-French Collaborative R&I Programme on Biotechnologies","award":["T\u00c9T_10-1-2011-0421"],"award-info":[{"award-number":["T\u00c9T_10-1-2011-0421"]}]},{"name":"Hungarian-French Collaborative R&I Programme on Biotechnologies","award":["T\u00c9T_10-1-2011-0421"],"award-info":[{"award-number":["T\u00c9T_10-1-2011-0421"]}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["NKFI K128875"],"award-info":[{"award-number":["NKFI K128875"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Innovation and Technology of Hungary from the National Research, Development, and Innovation Fund","award":["TKP2021-EGA-23"],"award-info":[{"award-number":["TKP2021-EGA-23"]}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Aminoglycoside antibiotics remain indispensable despite their ototoxicity. Like other sensorineural forms, aminoglycoside-induced hearing loss (AGIHL) has no effective pharmacotherapy. Oxidative stress, apoptosis, excitotoxicity and inflammation are key pathological factors of the disease. We hypothesised that selegiline, an irreversible monoamine oxidase-B (MAO-B) inhibitor used in Parkinson\u2019s disease, could be repurposed as an otoprotective agent against AGIHL and its effect on dopamine (DA) release from lateral olivocochlear (LOC) fibres, the efferent division of a protective feedback loop plays a major role in the protection against excitotoxicity. Selegiline mitigated AGIHL in BALB\/c mice in a dose-dependent manner at different auditory brainstem response frequencies, including 16\u00a0kHz, the hearing sensitivity optimum of the animals. It also enhanced the action potential-evoked DA release from LOC efferents in mouse cochlear preparation dose-dependently. Inhibition of DA reuptake contributed to its basic effect of saving DA from metabolism. Among four selegiline analogues tested, the one that increased LOC DA release also provided otoprotection. In contrast, neither safinamide (a reversible MAO-B inhibitor) nor LJP-1207 (a selective semicarbazide-sensitive amine oxidase\/vascular-adhesion protein 1 (SSAO\/VAP1) inhibitor) prevented AGIHL, despite their antioxidant and anti-inflammatory properties. The reversibility or lack of MAO-B inhibition in safinamide and LJP-1207, respectively, as well as the absence of the propargylamine moiety with known intrinsic neuroprotective activity in both molecules, may explain their ineffectiveness. Selegiline, or certain propargylamine analogues of it, offer a promising therapy against AGIHL by addressing its multifactorial pathology through antioxidant, antiapoptotic, neuroprotective, and anti-inflammatory actions, while enhancing endogenous DAergic protective mechanisms.<\/jats:p>","DOI":"10.1007\/s11064-025-04446-3","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:52:43Z","timestamp":1749793963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Protective Effect of Selegiline (R-deprenyl) in Aminoglycoside-Induced Hearing Loss"],"prefix":"10.1007","volume":"50","author":[{"given":"Vikt\u00f3ria","family":"Humli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Szepesy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Zsilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3","family":"Miklya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Tim\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd I.","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Polony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"G\u00e1borj\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy B.","family":"Halmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"M\u00e1tyus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Lendvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Sylvester","family":"Vizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Zelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"4446_CR1","unstructured":"WHO (2025) Deafness and hearing loss. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/deafness-and-hearing-loss. Accessed 10 Mar 2025"},{"key":"4446_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fncel.2017.00325","volume":"11","author":"ME O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan ME, Perez A, Lin R, Sajjadi A, Ricci AJ, Cheng AG (2017) Towards the prevention of aminoglycoside-related hearing loss. Front Cell Neurosci 11:325\u2013325. https:\/\/doi.org\/10.3389\/fncel.2017.00325","journal-title":"Front Cell Neurosci"},{"key":"4446_CR3","doi-asserted-by":"publisher","DOI":"10.1159\/000013861","author":"A Forge","year":"2000","unstructured":"Forge A, Schacht J (2000) Aminoglycoside antibiotics. Audiol Neurotol. https:\/\/doi.org\/10.1159\/000013861","journal-title":"Audiol Neurotol"},{"key":"4446_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.05.010","author":"L Dillard","year":"2021","unstructured":"Dillard L, Martinez R, Perez L, Fullerton A, Chadha S, McMahon C (2021) Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: a systematic review. J Infect. https:\/\/doi.org\/10.1016\/j.jinf.2021.05.010","journal-title":"J Infect"},{"key":"4446_CR5","doi-asserted-by":"publisher","first-page":"937861","DOI":"10.1155\/2011\/937861","volume":"2011","author":"ME Huth","year":"2011","unstructured":"Huth ME, Ricci AJ, Cheng AG (2011) Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol 2011:937861\u2013937861. https:\/\/doi.org\/10.1155\/2011\/937861","journal-title":"Int J Otolaryngol"},{"key":"4446_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1023\/a:1015434524040","volume":"26","author":"HC Dodson","year":"1997","unstructured":"Dodson HC (1997) Loss and survival of spiral ganglion neurons in the guinea pig after intracochlear perfusion with aminoglycosides. J Neurocytol 26:541\u2013556. https:\/\/doi.org\/10.1023\/a:1015434524040","journal-title":"J Neurocytol"},{"key":"4446_CR7","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.1073\/pnas.97.13.7597","volume":"97","author":"M Duan","year":"2000","unstructured":"Duan M, Agerman K, Ernfors P, Canlon B (2000) Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity. Proc Natl Acad Sci USA 97:7597\u20137602. https:\/\/doi.org\/10.1073\/pnas.97.13.7597","journal-title":"Proc Natl Acad Sci USA"},{"key":"4446_CR8","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2009.1218","author":"A Fransson","year":"2010","unstructured":"Fransson A, Maruyama J, Miller J, Ulfendahl M (2010) Post-treatment effects of local GDNF administration to the inner ears of deafened guinea pigs. J Neurotrauma. https:\/\/doi.org\/10.1089\/neu.2009.1218","journal-title":"J Neurotrauma"},{"key":"4446_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2007.07.026","volume":"29","author":"J Maruyama","year":"2008","unstructured":"Maruyama J, Miller JM, Ulfendahl M (2008) Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness. Neurobiol Dis 29:14\u201321. https:\/\/doi.org\/10.1016\/j.nbd.2007.07.026","journal-title":"Neurobiol Dis"},{"key":"4446_CR10","doi-asserted-by":"publisher","DOI":"10.3109\/00016487409129730","author":"J Ylikoski","year":"1974","unstructured":"Ylikoski J, Wers\u00e4ll J, Bj\u00f6rkroth B (1974) Degeneration of neural elements in the cochlea of the guinea-pig after damage to the organ of corti by ototoxic antibiotics. Acta Oto-Laryngologica Supplementum. https:\/\/doi.org\/10.3109\/00016487409129730","journal-title":"Acta Oto-Laryngologica Supplementum"},{"key":"4446_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23824","author":"A Fransson","year":"2017","unstructured":"Fransson A, Ulfendahl M (2017) Structural changes in the inner ear over time studied in the experimentally deafened guinea pig. J Neurosci Res. https:\/\/doi.org\/10.1002\/jnr.23824","journal-title":"J Neurosci Res"},{"key":"4446_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/s0378-5955(01)00303-3","volume":"158","author":"W Wu","year":"2001","unstructured":"Wu W, Sha S, McLaren J, Kawamoto K, Raphael Y, Schacht J (2001) Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res 158:165\u2013178. https:\/\/doi.org\/10.1016\/s0378-5955(01)00303-3","journal-title":"Hear Res"},{"key":"4446_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/sj.cdd.4401706","volume":"13","author":"H Jiang","year":"2006","unstructured":"Jiang H, Sha SH, Forge A, Schacht J (2006) Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Differ 13:20\u201330. https:\/\/doi.org\/10.1038\/sj.cdd.4401706","journal-title":"Cell Death Differ"},{"key":"4446_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00207","author":"SCY Lin","year":"2019","unstructured":"Lin SCY, Thorne PR, Housley GD, Vlajkovic SM (2019) Purinergic signaling and aminoglycoside ototoxicity: the opposing roles of P1 (adenosine) and P2 (ATP) receptors on cochlear hair cell survival. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2019.00207","journal-title":"Front Cell Neurosci"},{"key":"4446_CR15","doi-asserted-by":"publisher","first-page":"e12915","DOI":"10.1111\/cpr.12915","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu J, Ye J, Kong W, Zhang S, Zheng Y (2020) Programmed cell death pathways in hearing loss: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 53:e12915\u2013e12915. https:\/\/doi.org\/10.1111\/cpr.12915","journal-title":"Cell Prolif"},{"key":"4446_CR16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/nm1296-1338","volume":"2","author":"AS Basile","year":"1996","unstructured":"Basile AS, Huang JM, Xie C, Webster D, Berlin C, Skolnick P (1996) N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med 2:1338\u20131343. https:\/\/doi.org\/10.1038\/nm1296-1338","journal-title":"Nat Med"},{"key":"4446_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.heares.2017.01.003","volume":"349","author":"MC Liberman","year":"2017","unstructured":"Liberman MC, Kujawa SG (2017) Cochlear synaptopathy in acquired sensorineural hearing loss: manifestations and mechanisms. Hear Res 349:138\u2013147. https:\/\/doi.org\/10.1016\/j.heares.2017.01.003","journal-title":"Hear Res"},{"key":"4446_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2010.10.011","author":"K Hirose","year":"2010","unstructured":"Hirose K, Sato E (2010) Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea. Hear Res. https:\/\/doi.org\/10.1016\/j.heares.2010.10.011","journal-title":"Hear Res"},{"key":"4446_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-5955(02)00484-7","author":"M Duan","year":"2002","unstructured":"Duan M, Ulfendahl M, Laurell G, Counter S, Pyykk\u00f6 I, Borg E, Rosenhall U (2002) Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application. Hear Res. https:\/\/doi.org\/10.1016\/s0378-5955(02)00484-7","journal-title":"Hear Res"},{"key":"4446_CR20","first-page":"393","volume":"5","author":"J Knoll","year":"1972","unstructured":"Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5:393\u2013408","journal-title":"Adv Biochem Psychopharmacol"},{"key":"4446_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1176\/APPI.AJP.159.11.1869","volume":"159","author":"B Ja","year":"2002","unstructured":"Ja B, Jd A (2002) Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am J Psychiatry 159:1869\u20131875. https:\/\/doi.org\/10.1176\/APPI.AJP.159.11.1869","journal-title":"Am J Psychiatry"},{"key":"4446_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02082-0","author":"T T\u00e1bi","year":"2020","unstructured":"T\u00e1bi T, V\u00e9csei L, Youdim MB, Riederer P, Sz\u00f6k\u0151 \u00c9 (2020) Selegiline: a molecule with innovative potential. J Neural Transmission. https:\/\/doi.org\/10.1007\/s00702-019-02082-0","journal-title":"J Neural Transmission"},{"key":"4446_CR23","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/978-3-030-62059-2_237","volume-title":"NeuroPsychopharmacotherapy","author":"P Riederer","year":"2022","unstructured":"Riederer P, M\u00fcller T (2022) Selegiline for treating Parkinson\u2019s Disease. In: Riederer P, Laux G, Nagatsu T, Le W, Riederer C (eds) NeuroPsychopharmacotherapy. Springer, Cham, pp 3149\u20133157"},{"key":"4446_CR24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.63041572.x","author":"W Tatton","year":"1994","unstructured":"Tatton W, Ju W, Holland D, Tai C, Kwan M (1994) (\u2212)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem. https:\/\/doi.org\/10.1046\/j.1471-4159.1994.63041572.x","journal-title":"J Neurochem"},{"key":"4446_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90466-o","author":"M Carrillo","year":"1991","unstructured":"Carrillo M, Kanai S, Nokubo M, Kitani K (1991) (-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci. https:\/\/doi.org\/10.1016\/0024-3205(91)90466-o","journal-title":"Life Sci"},{"key":"4446_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/s0047-6374(99)00066-4","author":"W Maruyama","year":"1999","unstructured":"Maruyama W, Naoi M (1999) Neuroprotection by (-)-deprenyl and related compounds. Mech Age Dev. https:\/\/doi.org\/10.1016\/s0047-6374(99)00066-4","journal-title":"Mech Age Dev"},{"key":"4446_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-6499-0_33","author":"T M\u00fcller","year":"1998","unstructured":"M\u00fcller T, Kuhn W, Kr\u00fcger R, Przuntek H (1998) Selegiline as immunostimulant\u2013a novel mechanism of action? J Neural Transmission Supplementum. https:\/\/doi.org\/10.1007\/978-3-7091-6499-0_33","journal-title":"J Neural Transmission Supplementum"},{"key":"4446_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1853-9","author":"\u00c9 Sz\u00f6k\u0151","year":"2018","unstructured":"Sz\u00f6k\u0151 \u00c9, T\u00e1bi T, Riederer P, V\u00e9csei L, Magyar K (2018) Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson\u2019s disease. J Neural Transmission. https:\/\/doi.org\/10.1007\/s00702-018-1853-9","journal-title":"J Neural Transmission"},{"key":"4446_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.heares.2006.08.017","volume":"227","author":"J Ruel","year":"2007","unstructured":"Ruel J, Wang J, Rebillard G, Eybalin M, Lloyd R, Pujol R, Puel J-L (2007) Physiology, pharmacology and plasticity at the inner hair cell synaptic complex. Hear Res 227:19\u201327. https:\/\/doi.org\/10.1016\/j.heares.2006.08.017","journal-title":"Hear Res"},{"key":"4446_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/157015910791233123","volume":"8","author":"K Tabuchi","year":"2010","unstructured":"Tabuchi K, Nishimura B, Tanaka S, Hayashi K, Hirose Y, Hara A (2010) Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species. Curr Neuropharmacol 8:128\u2013134. https:\/\/doi.org\/10.2174\/157015910791233123","journal-title":"Curr Neuropharmacol"},{"key":"4446_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.03.071","author":"G Halmos","year":"2008","unstructured":"Halmos G, Horv\u00e1th T, Polony G, Fekete A, Kittel A, Vizi ES, van der Laan BF, Zelles T, Lendvai B (2008) The role of N-methyl-D-aspartate receptors and nitric oxide in cochlear dopamine release. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.03.071","journal-title":"Neuroscience"},{"key":"4446_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.01.023","author":"G Halmos","year":"2005","unstructured":"Halmos G, Dolevicz\u00e9nyi Z, R\u00e9p\u00e1ssy G, Kittel A, Vizi ES, Lendvai B, Zelles T (2005) D2 autoreceptor inhibition reveals oxygen-glucose deprivation-induced release of dopamine in guinea-pig cochlea. Neuroscience. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.01.023","journal-title":"Neuroscience"},{"key":"4446_CR33","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neuint.2011.05.015","volume":"59","author":"B Lendvai","year":"2011","unstructured":"Lendvai B, Halmos GB, Polony G, Kapocsi J, Horv\u00e1th T, Aller M, Vizi ES, Zelles T (2011) Chemical neuroprotection in the cochlea: the modulation of dopamine release from lateral olivocochlear efferents. Neurochem Int 59:150\u2013158. https:\/\/doi.org\/10.1016\/j.neuint.2011.05.015","journal-title":"Neurochem Int"},{"key":"4446_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuroscience.2014.01.057","volume":"265","author":"G Polony","year":"2014","unstructured":"Polony G, Humli V, And\u00f3 R, Aller M, Horv\u00e1th T, Harnos A, Tam\u00e1s L, Vizi ES, Zelles T (2014) Protective effect of rasagiline in aminoglycoside ototoxicity. Neuroscience 265:263\u2013273. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.01.057","journal-title":"Neuroscience"},{"key":"4446_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22062853","author":"J Szepesy","year":"2021","unstructured":"Szepesy J, Humli V, Farkas J, Miklya I, T\u00edm\u00e1r J, T\u00e1bi T, G\u00e1borj\u00e1n A, Polony G, Szirmai \u00c1, Tam\u00e1s L, K\u00f6les L, Vizi ES, Zelles T (2021) Chronic oral selegiline treatment mitigates age-related hearing loss in BALB\/c mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22062853","journal-title":"Int J Mol Sci"},{"key":"4446_CR36","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00955.2006","author":"K Darrow","year":"2007","unstructured":"Darrow K, Maison S, Liberman M (2007) Selective removal of lateral olivocochlear efferents increases vulnerability to acute acoustic injury. J Neurophysiol. https:\/\/doi.org\/10.1152\/jn.00955.2006","journal-title":"J Neurophysiol"},{"key":"4446_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2015.00094","author":"A Fuente","year":"2015","unstructured":"Fuente A (2015) The olivocochlear system and protection from acoustic trauma: a mini literature review. Front Syst Neurosci. https:\/\/doi.org\/10.3389\/fnsys.2015.00094","journal-title":"Front Syst Neurosci"},{"key":"4446_CR38","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/00016489309135819","volume":"113","author":"R Pujol","year":"1993","unstructured":"Pujol R, Puel JL, Gervais d\u2019Aldin C, Eybalin M (1993) Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol 113:330\u2013334. https:\/\/doi.org\/10.3109\/00016489309135819","journal-title":"Acta Otolaryngol"},{"key":"4446_CR39","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/BF00185388","volume":"252","author":"C d\u2019Aldin","year":"1995","unstructured":"d\u2019Aldin C, Eybalin M, Puel JL, Charachon G, Ladrech S, Renard N, Pujol R (1995) Synaptic connections and putative functions of the dopaminergic innervation of the guinea pig cochlea. Eur Arch Oto-Rhino-Laryngol 252:270\u2013274. https:\/\/doi.org\/10.1007\/BF00185388","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"key":"4446_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/00016489509139296","volume":"115","author":"PE Gil-Loyzaga","year":"1995","unstructured":"Gil-Loyzaga PE (1995) Neurotransmitters of the olivocochlear lateral efferent system: with an emphasis on dopamine. Acta Otolaryngol 115:222\u2013226. https:\/\/doi.org\/10.3109\/00016489509139296","journal-title":"Acta Otolaryngol"},{"key":"4446_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/s0378-5955(97)00023-3","volume":"107","author":"E Oestreicher","year":"1997","unstructured":"Oestreicher E, Arnold W, Ehrenberger K, Felix D (1997) Dopamine regulates the glutamatergic inner hair cell activity in guinea pigs. Hear Res 107:46\u201352. https:\/\/doi.org\/10.1016\/s0378-5955(97)00023-3","journal-title":"Hear Res"},{"key":"4446_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713334","author":"LG Harsing","year":"2023","unstructured":"Harsing LG, Timar J, Miklya I (2023) Striking neurochemical and behavioral differences in the mode of action of selegiline and rasagiline. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241713334","journal-title":"Int J Mol Sci"},{"key":"4446_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00277-z","author":"F Stocchi","year":"2022","unstructured":"Stocchi F, Antonini A, Berg D, Bergmans B, Jost W, Katzenschlager R, Kulisevsky J, Odin P, Valldeoriola F, Ray Chaudhuri K, Stocchi F, Antonini A, Berg D, Bergmans B, Jost W, Katzenschlager R, Kulisevsky J, Odin P, Valldeoriola F, Ray Chaudhuri K (2022) Safinamide in the treatment pathway of Parkinson\u2019s disease: a European Delphi consensus. NPJ Parkinson\u2019s Dis. https:\/\/doi.org\/10.1038\/s41531-022-00277-z","journal-title":"NPJ Parkinson\u2019s Dis"},{"key":"4446_CR44","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.7.1115","author":"M Onofrj","year":"2008","unstructured":"Onofrj M, Bonanni L, Thomas A (2008) An expert opinion on safinamide in Parkinson\u2019s disease. Expert Opin Investig Drugs. https:\/\/doi.org\/10.1517\/13543784.17.7.1115","journal-title":"Expert Opin Investig Drugs"},{"key":"4446_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt041","author":"D Morsali","year":"2013","unstructured":"Morsali D, Bechtold D, Lee W, Chauhdry S, Palchaudhuri U, Hassoon P, Snell D, Malpass K, Piers T, Pocock J, Roach A, Smith K (2013) Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. Brain: J Neurol. https:\/\/doi.org\/10.1093\/brain\/awt041","journal-title":"Brain: J Neurol"},{"key":"4446_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107712","author":"L Qian","year":"2021","unstructured":"Qian L, Li J, Sun X, Chen J, Dai Y, Huang Q, Jin Y, Duan Q (2021) Safinamide prevents lipopolysaccharide (LPS)-induced inflammation in macrophages by suppressing TLR4\/NF-\u03baB signaling. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2021.107712","journal-title":"Int Immunopharmacol"},{"key":"4446_CR47","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.089649","author":"L Salter-Cid","year":"2005","unstructured":"Salter-Cid L, Wang E, O\u2019Rourke A, Miller A, Gao H, Huang L, Garcia A, Linnik M (2005) Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. J Pharmacol Exp Therap. https:\/\/doi.org\/10.1124\/jpet.105.089649","journal-title":"J Pharmacol Exp Therap"},{"key":"4446_CR48","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7418","author":"M Salmi","year":"2018","unstructured":"Salmi M, Jalkanen S (2018) Vascular adhesion protein-1: a cell surface amine oxidase in translation. Antioxidants Redox Signal. https:\/\/doi.org\/10.1089\/ars.2017.7418","journal-title":"Antioxidants Redox Signal"},{"key":"4446_CR49","doi-asserted-by":"publisher","DOI":"10.2174\/092986708785133022","author":"P Dunkel","year":"2008","unstructured":"Dunkel P, Gelain A, Barlocco D, Haider N, Gyires K, Sperl\u00e1gh B, Magyar K, Maccioni E, Fadda A, M\u00e1tyus P (2008) Semicarbazide-sensitive amine oxidase\/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. Curr Med Chem. https:\/\/doi.org\/10.2174\/092986708785133022","journal-title":"Curr Med Chem"},{"key":"4446_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02288-8","author":"S Becchi","year":"2021","unstructured":"Becchi S, Buson A, Balleine B (2021) Inhibition of vascular adhesion protein 1 protects dopamine neurons from the effects of acute inflammation and restores habit learning in the striatum. J Neuroinflam. https:\/\/doi.org\/10.1186\/s12974-021-02288-8","journal-title":"J Neuroinflam"},{"key":"4446_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0306-4522(98)00461-8","volume":"90","author":"A G\u00e1borj\u00e1n","year":"1999","unstructured":"G\u00e1borj\u00e1n A, Lendvai B, Vizi ES (1999) Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea. Neuroscience 90:131\u2013138. https:\/\/doi.org\/10.1016\/s0306-4522(98)00461-8","journal-title":"Neuroscience"},{"key":"4446_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3940(99)00410-3","author":"A G\u00e1borj\u00e1n","year":"1999","unstructured":"G\u00e1borj\u00e1n A, Vizi ES (1999) Characterization of voltage dependent calcium channels on the lateral olivocochlear efferent fibers of the guinea pig. Neurosci Lett. https:\/\/doi.org\/10.1016\/s0304-3940(99)00410-3","journal-title":"Neurosci Lett"},{"key":"4446_CR53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2003.02897.x","author":"A K\u00f6falvi","year":"2003","unstructured":"K\u00f6falvi A, Vizi ES, Ledent C, Sperl\u00e1gh B (2003) Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur J Neurosci. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02897.x","journal-title":"Eur J Neurosci"},{"key":"4446_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90254-3","author":"ES Vizi","year":"1988","unstructured":"Vizi ES, Burnstock G (1988) Origin of ATP release in the rat vas deferens: concomitant measurement of [3H]noradrenaline and [14C]ATP. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/0014-2999(88)90254-3","journal-title":"Eur J Pharmacol"},{"key":"4446_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0378-5955(00)00053-8","volume":"144","author":"G Halmos","year":"2000","unstructured":"Halmos G, G\u00e1borj\u00e1n A, Lendvai B, R\u00e9p\u00e1ssy G, Szab\u00f3 LZ, Vizi ES (2000) Veratridine-evoked release of dopamine from guinea pig isolated cochlea. Hear Res 144:89\u201396. https:\/\/doi.org\/10.1016\/s0378-5955(00)00053-8","journal-title":"Hear Res"},{"key":"4446_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s10162-009-0204-9","author":"E Fernandez","year":"2010","unstructured":"Fernandez E, Ohlemiller K, Gagnon P, Clark W (2010) Protection against noise-induced hearing loss in young CBA\/J mice by low-dose kanamycin. J Assoc Res Otolaryngol. https:\/\/doi.org\/10.1007\/s10162-009-0204-9","journal-title":"J Assoc Res Otolaryngol"},{"key":"4446_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-018-1683-8","author":"SCY Lin","year":"2018","unstructured":"Lin SCY, Thorne PR, Housley GD, Vlajkovic SM (2018) Resistance to neomycin ototoxicity in the extreme basal (hook) region of the mouse cochlea. Histochem Cell Biol. https:\/\/doi.org\/10.1007\/s00418-018-1683-8","journal-title":"Histochem Cell Biol"},{"key":"4446_CR58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.2042-7158.1986.tb04468.x","volume":"38","author":"G Zsilla","year":"1986","unstructured":"Zsilla G, Foldi P, Held G, Szekely A, Knoll J (1986) The effect of repeated doses of (\u2013) deprenyl on the dynamics of monoaminergic transmission: comparison with clorgyline. Pol J Pharmacol Pharm 38:57\u201367","journal-title":"Pol J Pharmacol Pharm"},{"key":"4446_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2003.12.010","author":"ES Vizi","year":"2004","unstructured":"Vizi ES, Palkovits M, Lendvai B, Baranyi M, Kovacs KJ, Zelles T (2004) Distinct temperature-dependent dopamine-releasing effect of drugs of abuse in the olfactory bulb. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2003.12.010","journal-title":"Neurochem Int"},{"key":"4446_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.08.037","author":"G Zsilla","year":"2018","unstructured":"Zsilla G, Hegyi DE, Baranyi M, Vizi ES (2018) 3,4-Methylenedioxymethamphetamine, mephedrone, and \u03b2-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2018.08.037","journal-title":"Eur J Pharmacol"},{"key":"4446_CR61","doi-asserted-by":"publisher","DOI":"10.2471\/B09180","volume-title":"WHO recommendations for management of serious bacterial infections in infants aged 0\u201359 days","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) WHO recommendations for management of serious bacterial infections in infants aged 0\u201359 days. World Health Organization"},{"key":"4446_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219600","author":"E Butcher","year":"2019","unstructured":"Butcher E, Dezateux C, Cortina-Borja M, Knowles R (2019) Prevalence of permanent childhood hearing loss detected at the universal newborn hearing screen: Systematic review and meta-analysis. PloS One. https:\/\/doi.org\/10.1371\/journal.pone.0219600","journal-title":"PloS One"},{"key":"4446_CR63","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0378-5955(96)00075-5","volume":"98","author":"W Clerici","year":"1996","unstructured":"Clerici W, Hensley K, DiMartino D, Butterfield D (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 98:116\u2013124. https:\/\/doi.org\/10.1016\/0378-5955(96)00075-5","journal-title":"Hear Res"},{"key":"4446_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10162-009-0198-3","volume":"11","author":"E Sato","year":"2010","unstructured":"Sato E, Shick HE, Ransohoff RM, Hirose K (2010) Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury. J Assoc Res Otolaryngol 11:223\u2013234. https:\/\/doi.org\/10.1007\/s10162-009-0198-3","journal-title":"J Assoc Res Otolaryngol"},{"key":"4446_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.heares.2012.08.002","volume":"294","author":"AL Vlasits","year":"2012","unstructured":"Vlasits AL, Simon JA, Raible DW, Rubel EW, Owens KN (2012) Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin. Hear Res 294:153\u2013165. https:\/\/doi.org\/10.1016\/j.heares.2012.08.002","journal-title":"Hear Res"},{"key":"4446_CR66","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4720-11.2012","author":"SF Maison","year":"2012","unstructured":"Maison SF, Liu X-P, Eatock RA, Sibley DR, Grandy DK, Liberman MC (2012) Dopaminergic signaling in the cochlea: receptor expression patterns and deletion phenotypes. J Neurosci. https:\/\/doi.org\/10.1523\/JNEUROSCI.4720-11.2012","journal-title":"J Neurosci"},{"key":"4446_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-008-9796-4","author":"Z Dolevicz\u00e9nyi","year":"2008","unstructured":"Dolevicz\u00e9nyi Z, Vizi ES, Gacs\u00e1lyi I, Pallagi K, Volk B, H\u00e1rsing LG, Halmos G, Lendvai B, Zelles T (2008) 5-HT6\/7 receptor antagonists facilitate dopamine release in the cochlea via a GABAergic disinhibitory mechanism. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-008-9796-4","journal-title":"Neurochem Res"},{"key":"4446_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.05.017","author":"Z Dolevicz\u00e9nyi","year":"2005","unstructured":"Dolevicz\u00e9nyi Z, Halmos G, R\u00e9p\u00e1ssy G, Vizi ES, Zelles T, Lendvai B (2005) Cochlear dopamine release is modulated by group II metabotropic glutamate receptors via GABAergic neurotransmission. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2005.05.017","journal-title":"Neurosci Lett"},{"key":"4446_CR69","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.drudis.2021.11.009","volume":"27","author":"B Isherwood","year":"2022","unstructured":"Isherwood B, Gon\u00e7alves AC, Cousins R, Holme R (2022) The global hearing therapeutic pipeline: 2021. Drug Discovery Today 27:912\u2013922. https:\/\/doi.org\/10.1016\/j.drudis.2021.11.009","journal-title":"Drug Discovery Today"},{"key":"4446_CR70","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77286","author":"HM Rinc\u00f3n","year":"2025","unstructured":"Rinc\u00f3n HM, Arias PE, Rojas PC, Orozco GA, Lopez BC, Garc\u00eda AV, Escobar UA, Duncan VC (2025) Exploring the potential of stem cells: a systematic review on cellular therapy for sensorineural hearing loss. Cureus. https:\/\/doi.org\/10.7759\/cureus.77286","journal-title":"Cureus"},{"key":"4446_CR71","doi-asserted-by":"publisher","DOI":"10.2217\/rme.13.32","author":"Z Hu","year":"2013","unstructured":"Hu Z, Ulfendahl M (2013) The potential of stem cells for the restoration of auditory function in humans. Regen Med. https:\/\/doi.org\/10.2217\/rme.13.32","journal-title":"Regen Med"},{"key":"4446_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03023-5","author":"H Wang","year":"2024","unstructured":"Wang H, Chen Y, Lv J, Cheng X, Cao Q, Wang D, Zhang L, Zhu B, Shen M, Xu C, Xun M, Wang Z, Tang H, Hu S, Cui C, Jiang L, Yin Y, Guo L, Zhou Y, Han L, Gao Z, Zhang J, Yu S, Gao K, Wang J, Chen B, Wang W, Chen Z-Y, Li H, Shu Y (2024) Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results. Nat Med. https:\/\/doi.org\/10.1038\/s41591-024-03023-5","journal-title":"Nat Med"},{"key":"4446_CR73","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2022-0046","author":"M Vaz de Freitas","year":"2022","unstructured":"Vaz de Freitas M, Fr\u00e2ncio L, Haleva L, da Silveira MU (2022) Protection is not always a good thing: the immune system\u2019s impact on gene therapy. Genet Mol Biol. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2022-0046","journal-title":"Genet Mol Biol"},{"key":"4446_CR74","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2023.29255.pwl","author":"PWL Tai","year":"2023","unstructured":"Tai PWL (2023) Integration of gene therapy vectors: a risk factor for tumorigenesis or another commensal property of adeno-associated viruses that benefits long-term transgene expression? Hum Gene Ther. https:\/\/doi.org\/10.1089\/hum.2023.29255.pwl","journal-title":"Hum Gene Ther"},{"key":"4446_CR75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2416453122","author":"J Li","year":"2025","unstructured":"Li J, Oh S, Liu C, Zhao B (2025) Inhibition of GABARAP or GABARAPL1 prevents aminoglycoside- induced hearing loss. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.2416453122","journal-title":"Proc Natl Acad Sci USA"},{"key":"4446_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1305433","author":"L Han","year":"2024","unstructured":"Han L, Wang Z, Wang D, Gao Z, Hu S, Shi D, Shu Y (2024) Mechanisms and otoprotective strategies of programmed cell death on aminoglycoside-induced ototoxicity. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2023.1305433","journal-title":"Front Cell Dev Biol"},{"key":"4446_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-022-00550-x","author":"S Dhillon","year":"2023","unstructured":"Dhillon S (2023) Sodium thiosulfate: pediatric first approval. Paediatric Drugs. https:\/\/doi.org\/10.1007\/s40272-022-00550-x","journal-title":"Paediatric Drugs"},{"key":"4446_CR78","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0000911520.74290.b0","author":"D Aschenbrenner","year":"2023","unstructured":"Aschenbrenner D (2023) Drug approved to prevent cisplatin-associated ototoxicity in children. Am J Nurs. https:\/\/doi.org\/10.1097\/01.NAJ.0000911520.74290.b0","journal-title":"Am J Nurs"},{"key":"4446_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216545","author":"W Tan","year":"2023","unstructured":"Tan W, Vlajkovic S (2023) Molecular characteristics of cisplatin-induced ototoxicity and therapeutic interventions. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242216545","journal-title":"Int J Mol Sci"},{"key":"4446_CR80","unstructured":"European Medicines Agency (2023) Pedmarqsi. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/pedmarqsi. Accessed 1 Oct 2025"},{"issue":"3","key":"4446_CR81","doi-asserted-by":"publisher","first-page":"28","DOI":"10.29245\/2572.942X\/2016\/3.1032","volume":"1","author":"PL McGeer","year":"2016","unstructured":"McGeer PL, McGeer EG, Lee M (2016) Medical uses of sodium thiosulfate. J Neurol Neuromed 1(3):28\u201330. https:\/\/doi.org\/10.29245\/2572.942X\/2016\/3.1032","journal-title":"J Neurol Neuromed"},{"key":"4446_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1992.tb01860.x","author":"J Knoll","year":"1992","unstructured":"Knoll J (1992) (\u2013)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic system. J Am Geriatrics Soc. https:\/\/doi.org\/10.1111\/j.1532-5415.1992.tb01860.x","journal-title":"J Am Geriatrics Soc"},{"key":"4446_CR83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1984.tb16228.x","author":"LG H\u00e1rsing","year":"1984","unstructured":"H\u00e1rsing LG, Vizi ES (1984) Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (\u2013)-deprenyl. Br J Pharmacol. https:\/\/doi.org\/10.1111\/j.1476-5381.1984.tb16228.x","journal-title":"Br J Pharmacol"},{"key":"4446_CR84","first-page":"45","volume":"25","author":"J Knoll","year":"1987","unstructured":"Knoll J (1987) (1987) R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron. J Neural Transmission Supplementa 25:45\u201366","journal-title":"J Neural Transmission Supplementa"},{"key":"4446_CR85","first-page":"653","volume":"40","author":"K Tekes","year":"1988","unstructured":"Tekes K, Tothfalusi L, Gaal J, Magyar K (1988) Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain. Pol J Pharmacol Pharm 40:653\u2013658","journal-title":"Pol J Pharmacol Pharm"},{"key":"4446_CR86","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1471-4159.1993.tb03181.x","volume":"60","author":"D Sulzer","year":"1993","unstructured":"Sulzer D, Maidment N, Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60:527\u2013535. https:\/\/doi.org\/10.1111\/j.1471-4159.1993.tb03181.x","journal-title":"J Neurochem"},{"key":"4446_CR87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2010.07109.x","author":"GM Miller","year":"2011","unstructured":"Miller GM (2011) The emerging role of trace amine associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07109.x","journal-title":"J Neurochem"},{"key":"4446_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.02.010","author":"D Sulzer","year":"2011","unstructured":"Sulzer D (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2011.02.010","journal-title":"Neuron"},{"key":"4446_CR89","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0006-2952(79)90376-9","volume":"28","author":"B Ekstedt","year":"1979","unstructured":"Ekstedt B, Magyar K, Knoll J (1979) Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment? Biochem Pharmacol 28:919\u2013923. https:\/\/doi.org\/10.1016\/0006-2952(79)90376-9","journal-title":"Biochem Pharmacol"},{"key":"4446_CR90","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.67041532.x","author":"I Lamensdorf","year":"1996","unstructured":"Lamensdorf I, Youdim MBH, Finberg JPM (1996) Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo. J Neurochem. https:\/\/doi.org\/10.1046\/j.1471-4159.1996.67041532.x","journal-title":"J Neurochem"},{"key":"4446_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-9113-2_32","author":"R Heikkila","year":"1990","unstructured":"Heikkila R, Terleckyj I, Sieber B (1990) Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOP. J Neural Transmission Supplementum. https:\/\/doi.org\/10.1007\/978-3-7091-9113-2_32","journal-title":"J Neural Transmission Supplementum"},{"key":"4446_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/cne.10804","author":"T Vitalis","year":"2003","unstructured":"Vitalis T, Alvarez C, Chen K, Shih JC, Gaspar P, Cases O (2003) Developmental expression pattern of monoamine oxidases in sensory organs and neural crest derivatives. J Compar Neurol. https:\/\/doi.org\/10.1002\/cne.10804","journal-title":"J Compar Neurol"},{"key":"4446_CR93","doi-asserted-by":"publisher","DOI":"10.2174\/1874104501711010001","author":"H Kal\u00e1sz","year":"2017","unstructured":"Kal\u00e1sz H, Tekes K, Faigl E, P\u00f6st\u00e9nyi Z, Berekm\u00e9ri E, Karvaly G, Adeghate E (2017) Monitoring the level of 14C-labelled selegiline following oral administration. Open Med Chem J. https:\/\/doi.org\/10.2174\/1874104501711010001","journal-title":"Open Med Chem J"},{"key":"4446_CR94","first-page":"179","volume":"1","author":"G Ehret","year":"1976","unstructured":"Ehret G (1976) Development of absolute auditory thresholds in the house mouse (Mus musculus). J Am Audiol Soc 1:179\u2013184","journal-title":"J Am Audiol Soc"},{"key":"4446_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.10.019","author":"T Hoshino","year":"2011","unstructured":"Hoshino T, Tabuchi K, Nishimura B, Tanaka S, Nakayama M, Ishii T, Warabi E, Yanagawa T, Shimizu R, Yamamoto M, Hara A (2011) Protective role of Nrf2 in age-related hearing loss and gentamicin ototoxicity. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2011.10.019","journal-title":"Biochem Biophys Res Commun"},{"key":"4446_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2011.10.007","author":"H Xiao","year":"2011","unstructured":"Xiao H, Lv F, Xu W, Zhang L, Jing P, Cao X (2011) Deprenyl prevents MPP(+)-induced oxidative damage in PC12 cells by the upregulation of Nrf2-mediated NQO1 expression through the activation of PI3K\/Akt and Erk. Toxicology. https:\/\/doi.org\/10.1016\/j.tox.2011.10.007","journal-title":"Toxicology"},{"key":"4446_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2022.06.006","author":"L Wu","year":"2022","unstructured":"Wu L, Chen M, Li M, Wang Y, Li Y, Zheng L, Ke Z, Liu K, Qiao Y, Shi X (2022) Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3\/caspase-1\/gasdermin D-induced inflammasome activation and hair cell pyroptosis. Mol Immunol. https:\/\/doi.org\/10.1016\/j.molimm.2022.06.006","journal-title":"Mol Immunol"},{"key":"4446_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.11.047","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, Zhou R (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. https:\/\/doi.org\/10.1016\/j.cell.2014.11.047","journal-title":"Cell"},{"key":"4446_CR99","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-23-01879","author":"J Fang","year":"2025","unstructured":"Fang J, Li Z, Wang P, Zhang X, Mao S, Li Y, Yu D, Li X, Xing Y, Shi H, Yin S (2025) Inhibition of the NLRP3 inflammasome attenuates spiral ganglion neuron degeneration in aminoglycoside-induced hearing loss. Neural Regen Res. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01879","journal-title":"Neural Regen Res"},{"key":"4446_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109287","author":"GE Gregory","year":"2023","unstructured":"Gregory GE, Munro KJ, Couper KN, Pathmanaban ON, Brough D (2023) The NLRP3 inflammasome as a target for sensorineural hearing loss. Clin Immunol. https:\/\/doi.org\/10.1016\/j.clim.2023.109287","journal-title":"Clin Immunol"},{"key":"4446_CR101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1996.tb01333.x","author":"J Zheng","year":"1996","unstructured":"Zheng J, Gao W (1996) Differential damage to auditory neurons and hair cells by ototoxins and neuroprotection by specific neurotrophins in rat cochlear organotypic cultures. Eur J Neurosci. https:\/\/doi.org\/10.1111\/j.1460-9568.1996.tb01333.x","journal-title":"Eur J Neurosci"},{"key":"4446_CR102","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.060122","author":"J Tan","year":"2006","unstructured":"Tan J, Shepherd RK (2006) Aminoglycoside-induced degeneration of adult spiral ganglion neurons involves differential modulation of tyrosine kinase B and p75 neurotrophin receptor signaling. Am J Pathol. https:\/\/doi.org\/10.2353\/ajpath.2006.060122","journal-title":"Am J Pathol"},{"key":"4446_CR103","doi-asserted-by":"publisher","DOI":"10.1159\/000192953","author":"S Pfannenstiel","year":"2009","unstructured":"Pfannenstiel S, Praetorius M, Plinkert P, Brough D, Staecker H (2009) Bcl-2 gene therapy prevents aminoglycoside-induced degeneration of auditory and vestibular hair cells. Audiol Neurootol. https:\/\/doi.org\/10.1159\/000192953","journal-title":"Audiol Neurootol"},{"key":"4446_CR104","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2022.2129761","author":"A Abdanipour","year":"2023","unstructured":"Abdanipour A, Mirzaei M, Anarkooli IJ, Mohammadi P (2023) Effect of selegiline as a monomine oxidase B inhibitor on the expression of neurotrophin mRNA levels in a contusion rat model of spinal cord injury. Neurol Res. https:\/\/doi.org\/10.1080\/01616412.2022.2129761","journal-title":"Neurol Res"},{"key":"4446_CR105","doi-asserted-by":"publisher","first-page":"11059","DOI":"10.3390\/ijms231911059","volume":"23","author":"M Naoi","year":"2022","unstructured":"Naoi M, Maruyama W, Shamoto-Nagai M (2022) Neuroprotective function of rasagiline and selegiline, inhibitors of type B monoamine oxidase, and role of monoamine oxidases in synucleinopathies. Int J Mol Sci 23:11059. https:\/\/doi.org\/10.3390\/ijms231911059","journal-title":"Int J Mol Sci"},{"key":"4446_CR106","doi-asserted-by":"publisher","DOI":"10.2174\/0929867043365305","author":"P M\u00e1tyus","year":"2004","unstructured":"M\u00e1tyus P, Dajka-Hal\u00e1sz B, F\u00f6ldi A, Haider N, Barlocco D, Magyar K (2004) Semicarbazide-sensitive amine oxidase: current status and perspectives. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867043365305","journal-title":"Curr Med Chem"},{"key":"4446_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/srep39863","author":"\u00c1 Horv\u00e1th","year":"2017","unstructured":"Horv\u00e1th \u00c1, Menghis A, Botz B, Borb\u00e9ly \u00c9, Kem\u00e9ny \u00c1, T\u00e9kus V, Csepregi JZ, M\u00f3csai A, Juh\u00e1sz T, Z\u00e1k\u00e1ny R, Bogd\u00e1n D, M\u00e1tyus P, Keeble J, Pint\u00e9r E, Helyes Z (2017) Analgesic and anti-inflammatory effects of the novel semicarbazide-sensitive amine-oxidase inhibitor SzV-1287 in chronic arthritis models of the mouse. Sci Rep. https:\/\/doi.org\/10.1038\/srep39863","journal-title":"Sci Rep"},{"key":"4446_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-017-1740-9","author":"K Inaba-Hasegawa","year":"2017","unstructured":"Inaba-Hasegawa K, Shamoto-Nagai M, Maruyama W, Naoi M (2017) Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline. J Neural Transmission. https:\/\/doi.org\/10.1007\/s00702-017-1740-9","journal-title":"J Neural Transmission"},{"key":"4446_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386467-3.00004-2","author":"K Magyar","year":"2011","unstructured":"Magyar K (2011) The pharmacology of selegiline. Int Rev Neurobiol. https:\/\/doi.org\/10.1016\/B978-0-12-386467-3.00004-2","journal-title":"Int Rev Neurobiol"},{"key":"4446_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(01)00391-8","author":"MBH Youdim","year":"2002","unstructured":"Youdim MBH, Weinstock M (2002) Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline. Mech Age Dev. https:\/\/doi.org\/10.1016\/S0047-6374(01)00391-8","journal-title":"Mech Age Dev"},{"key":"4446_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00905","author":"L Bellusci","year":"2017","unstructured":"Bellusci L, Laurino A, Sabatini M, Sestito S, Lenzi P, Raimondi L, Rapposelli S, Biagioni F, Fornai F, Salvetti A, Rossi L, Zucchi R, Chiellini G (2017) New Insights into the potential roles of 3-iodothyronamine (T1AM) and newly developed thyronamine-like TAAR1 agonists in neuroprotection. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00905","journal-title":"Front Pharmacol"},{"key":"4446_CR112","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0912433","author":"A Babusyte","year":"2013","unstructured":"Babusyte A, Kotthoff M, Fiedler J, Krautwurst D (2013) Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2. J Leukocyte Biol. https:\/\/doi.org\/10.1189\/jlb.0912433","journal-title":"J Leukocyte Biol"},{"key":"4446_CR113","doi-asserted-by":"publisher","first-page":"11576","DOI":"10.3390\/ijms222111576","volume":"22","author":"DA Barnes","year":"2021","unstructured":"Barnes DA, Galloway DA, Hoener MC, Berry MD, Moore CS (2021) TAAR1 expression in human macrophages and brain tissue: a potential novel facet of MS neuroinflammation. Int J Mol Sci 22:11576. https:\/\/doi.org\/10.3390\/ijms222111576","journal-title":"Int J Mol Sci"},{"key":"4446_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147811","author":"D Leo","year":"2022","unstructured":"Leo D, Targa G, Espinoza S, Villers A, Gainetdinov RR, Ris L (2022) Trace amine associate receptor 1 (TAAR1) as a new target for the treatment of cognitive dysfunction in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23147811","journal-title":"Int J Mol Sci"},{"key":"4446_CR115","unstructured":"United States. Department of Health and Human S, United States. Food and Drug A, Center for Drug Evaluation and Research (2005) Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers: pharmacology and toxicology. Center for Drug Evaluation and Research, Rockville"},{"key":"4446_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(78)90128-0","author":"M Schechter","year":"1978","unstructured":"Schechter M (1978) Stimulus properties of d-amphetamine as compared to l-amphetamine. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/0014-2999(78)90128-0","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4446_CR117","first-page":"189","volume":"7","author":"C Chiueh","year":"1974","unstructured":"Chiueh C, Moore K (1974) Relative potencies of d- and l-amphetamine on the release of dopamine from cat brain in vivo. Res Commun Chem Pathol Pharmacol 7(1):189\u2013199","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"4446_CR118","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428320","author":"E Schi\u00f8rring","year":"1979","unstructured":"Schi\u00f8rring E (1979) An open field study of stereotyped locomotor activity in amphetamine-treated rats. Psychopharmacology. https:\/\/doi.org\/10.1007\/BF00428320","journal-title":"Psychopharmacology"},{"key":"4446_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2010.09.008","author":"W White","year":"2010","unstructured":"White W, Hundley MB, White IM (2010) The effects of dose and repeated administration on the longer-term hypophagia produced by amphetamine in rats. Pharmacol Biochem Behavior. https:\/\/doi.org\/10.1016\/j.pbb.2010.09.008","journal-title":"Pharmacol Biochem Behavior"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04446-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04446-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04446-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T16:44:23Z","timestamp":1750697063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04446-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["4446"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04446-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures were approved by the Animal Use Committee of the HUN-REN Institute of Experimental Medicine and the Animal Experimentation Committee of Semmelweis University. The study was approved by the Scientific Ethical Committee on Animal Experimentation (\u00c1TET) and the National Food Chain Safety Office (N\u00c9BIH), Animal Welfare Department (Permit Number: XIV-I-001\/1028-4\/2012; PE\/EA\/00093-5\/2023). The study was conducted following Directive 2010\/63\/EU on the protection of animals used for scientific purposes and Hungarian Government Decree 40\/2013 (II. 14.). Every effort was made to minimise animal suffering and to reduce the number of animals used. The mice were handled in strict compliance with the principles outlined in the NIH guidelines (National Research Council, 2011, Guide for the Care and Use of Laboratory Animals: 8th Edition).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"200"}}